Crosstalk Between Viral Envelop‐E Protein and Host Innate Immune System: Exploring Pharmacological Targets and Agents
Reviews in Medical Virology · 2025
DOI: 10.1002/rmv.70067 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, 2025. Verfasst von Satyam Shekhar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Health Sciences, Central University of South Bihar, Gaya, India. Hauptthemen laut MEDLINE: Immunity, Innate, Antiviral Agents, Host-Pathogen Interactions, Viral Envelope Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 146 Literaturangaben.
Abstract (Originalsprache)
The Envelope (E)‐protein is a key structural element of enveloped viruses that plays a significant role in host‐pathogen interactions, viral growth, and hijacking of host innate immune system. Due to lack of antiviral agents and significant adverse effects and less affordability of vaccines, the E‐protein targeted drug development is gaining critical attention among the researchers. The present review explores the structural and genomic diversities of E‐protein among animal viruses with special interest to flaviviruses, coronaviruses, and herpesviruses. E‐protein's viroporin activity damages host cell membrane and induces inflammation that advances the disease progression. The review also explains the viroporin‐mediated NOD‐like receptor family pyrin domain‐containing 3 (NLRP3), Toll‐like receptors (TLRs), nucleotide‐binding oligomerisation domain (NOD)‐like receptors (NLRs), and retinoic acid‐inducible gene I (RIG‐I)‐like receptors (RLRs)‐linked cellular mechanisms in virus‐mediated inflammation. The E‐protein is considered an alternative promising antiviral target as its functional domain is conserved. This review further enlists the natural, and synthetic inhibitors of E‐protein in the development of antiviral agents based on computational, in vitro, and in vivo studies. The E‐protein's universal conservation ability to fasten to cellular membranes and limited structural data imparts significant challenge to selective drug inhibition. The present review highlights that the E‐protein together with multiple viral factors will boost treatment performance while minimising viral resistance. In addition, broad‐range inhibitors targeting E‐proteins have the potential to produce single treatment solutions in combating viral infections including several viral strains. In conclusion, E‐protein targeted drug would be beneficial in developing potential antiviral agents with high drug specificity, and less viral resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, School of Health Sciences, Central University of South Bihar, Gaya, India.
- Department of Pharmacology, School of Health Sciences, Central University of Punjab, Bathinda, India.
ORCID-Profile: Debapriya Garabadu
Zitieren
APA
Shekhar, S., Maurya, A., Sandeep, Bhattamisra, S. K., Singh, G. K., & Garabadu, D. (2025). Crosstalk Between Viral Envelop‐E Protein and Host Innate Immune System: Exploring Pharmacological Targets and Agents. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70067
Vancouver
Shekhar S, Maurya A, Sandeep, Bhattamisra SK, Singh GK, Garabadu D. Crosstalk Between Viral Envelop‐E Protein and Host Innate Immune System: Exploring Pharmacological Targets and Agents. Reviews in Medical Virology. 2025. doi:10.1002/rmv.70067
BibTeX
@article{Shekhar2025,
author = {Shekhar, Satyam and Maurya, Arvind and Sandeep and Bhattamisra, Subrat Kumar and Singh, Gireesh Kumar and Garabadu, Debapriya},
title = {Crosstalk Between Viral Envelop‐E Protein and Host Innate Immune System: Exploring Pharmacological Targets and Agents},
journal = {Reviews in Medical Virology},
year = {2025},
doi = {10.1002/rmv.70067}
}
EUVIMED